China National Medicines Corporation Ltd. Class ASSE: 600511

Announcement on Convening the Q3 2024 Performance Briefing

· Issued by China National Medicines Corporation Ltd. Class A via Shanghai Stock Exchange
Announcement on Convening the Q3 2024 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment